TP53 and breast cancer: Similar HIPK2 cytoplasmic localization was found in breast cancer tissues with overexpression of integrin alpha(6)beta(4), which is also involved in impairment of p53 apoptotic activity [42], indicating that HIPK2 cytoplasmic relocalization may be a negative marker for p53 function.